Shu Kurosaki Overview
- Company
- Synchronicity Ph...
- Primary Position
-
Chief Financial...
Shu Kurosaki General Information
Biography
Mr. Shu Kurosaki served as Controller at Novome Biotechnologies. He serves as Chief Financial Officer at Synchronicity Therapeutics. Previously, he was the Vice President, Finance & Administration at MacuSight, a developer for the treatment of serious ocular diseases. While at MacuSight, he managed the financial and general operational aspects of the Company and played a key financial role in a license collaboration agreement with a publicly-traded ophthalmology company. Prior to MacuSight, he served as Director of Finance at Oculex Pharmaceuticals, which was acquired by Allergan in 2003 and ultimately marketed Ozurdex®, a biodegradable implant that has received regulatory approval in the US and abroad. He also served as an audit manager at PricewaterhouseCoopers and is an active Certified Public Accountant in California. He received his B.S. in Business Administration from the University of California at Berkeley.
Contact Information
Address
- 1416 Saratoga Avenue
- Suite 133
- San Jose, CA 95129
- United States
Shu Kurosaki Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Synchronicity Pharma | Company | Chief Financial Officer | San Jose, CA | Drug Discovery |
Shu Kurosaki FAQs
-
Who is Shu Kurosaki?
Mr. Shu Kurosaki served as Controller at Novome Biotechnologies.
-
How much does Shu Kurosaki typically invest?
Shu Kurosaki's median deal size is .
-
What is Shu Kurosaki’s main position?
Shu Kurosaki’s primary position is Chief Financial Officer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
